Prognostic value of serum cystatin C and N-terminal pro b-type natriuretic peptide in patients with acute heart failure

European Journal of Internal Medicine

Volumn 23, Issue 7, 2012, Pages 599-603

  Pérez Calvo, Juan Ignacio ^a,b   Ruiz Ruiz, Francisco José ^a   Carrasco Sánchez, Francisco Javier ^c   Morales Rull, José Luis ^d   Manzano Fernández, Sergio ^e   Galisteo Almeda, Luis ^c   Pascual Figal, Domingo ^e  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN IIS ARAGÓN   (Spain)

^c HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^d HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Acute heart failure; Biomarkers; Cystatin C; NTpro BNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CHOLESTEROL; CREATININE; CYSTATIN C; HEMOGLOBIN; UREA;

ACUTE HEART FAILURE; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HOSPITAL PATIENT; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; CREATININE; CYSTATIN C; FEMALE; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 84865697047     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.06.002     Document Type: Article

References (28)

1. F.A. McAlister, J. Ezekowitz, M. Tonelli, and P.W. Armstrong Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study Circulation 109 2004 1004 1009
2. H.L. Hillege, A.R. Girbes, P.J. de Kam, F. Boomsma, D. de Zeeuw, and A. Charlesworth Renal function, neurohormonal activation, and survival in patients with chronic heart failure Circulation 102 2000 203 210
3. J. Lassus, and V.-P. Harjola Cystatin C: a step forward in assessing kidney function and cardiovascular risk Heart Fail Rev 17 2012 251 261
4. O.F. Laterza, C.P. Price, and M.G. Scott Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 48 2002 699 707
5. M.G. Shlipak, M.J. Sarnak, R. Katz, L.F. Fried, S.L. Seliger, and A.B. Newman Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 2005 2049 2060
6. M.G. Shlipak, R. Katz, M.J. Sarnak, L.F. Fried, A.B. Newman, and C. Stehman-Breen Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease Ann Intern Med 145 2006 237 246
7. M.J. Sarnak, R. Katz, C.O. Stehman-Breen, L.F. Fried, N.S. Jenny, and B.M. Psaty Cystatin C concentration as a risk factor for heart failure in older adults Ann Intern Med 142 2005 497 505
8. T. Arimoto, Y. Takeishi, T. Niizeki, N. Takabatake, H. Okuyama, and A. Fukui Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure J Card Fail 11 2005 595 601
9. F.J. Carrasco-Sánchez, L. Galisteo-Almeda, I. Páez-Rubio, F.J. Martínez-Marcos, C. Camacho-Vázquez, and C. Ruiz-Frutos Prognostic value of Cystatin C on admission in heart failure with preserved ejection fraction J Card Fail 17 2011 31 38
10. U. Alehagen, U. Dahlström, and T.L. Lindahl Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care Eur J Heart Fail 11 2009 354 360
11. J. Lassus, V.P. Harjola, R. Sund, K. Sirillä-Waris, J. Melin, and K. Peukurinen Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP Eur Heart J 28 2007 1841 1847
12. C.Y. Campbell, W. Clarke, H. Park, N. Haq, B.B. Barone, and D.J. Brotman Usefulness of cystatin C and prognosis following admission for acute heart failure Am J Cardiol 104 2009 389 392
13. S. Manzano-Fernandez, M. Boronat-Garcia, M.D. Albaladejo-Oton, P. Pastor, I.P. Garrido, and F.J. Pastor-Pérez Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic peptide and cardiac troponin T in patients with acute heart failure Am J Cardiol 103 2009 1753 1759
14. H. Naruse, J. Ishii, T. Kawai, K. Hatori, M. Ishikawa, and M. Okumura Cystatin C in acute heart failure without advanced renal impairment Am J Med 122 2009 566 573
15. M.S. Nieminen, M. Bohm, M.R. Cowie, H. Drexler, G.S. Filippatos, and G. Jondeau ESC Committee for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology Eur Heart J 26 2005 384 416
16. J.L. Januzzi, R. van Kimmenade, J. Lainchbury, A. Bayes-Genis, J. Ordonez-Llanos, and M. Santalo-Bel NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study Eur Heart J 27 2006 330 337
17. M.G. Shlipak, R. Katz, L.F. Fried, N.S. Jenny, C.O. Stehman-Breen, and A.B. Newman Cystatin-C and mortality in elderly persons with heart failure J Am Coll Cardiol 45 2005 268 271
18. L.A. Stevens, and A.S. Levey Chronic kidney disease in the elderly-how to assess risk N Engl J Med 352 2005 2122 2124
19. V.R. Dharnidharka, C. Kwon, and G. Stevens Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis Am J Kidney Dis 40 2002 221 226
20. J.F. Roos, J. Doust, S.E. Tett, and C.M. Kirkpatrick Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children - a metaanalysis Clin Biochem 40 2007 383 391
21. M.A. Torralba-Cabeza, S. Olivera, D.A. Hughes, G.M. Pastores, R.N. Mateo, and J.I. Pérez-Calvo Cystatin C and NT-proBNP as prognostic biomarkers in Fabry disease Mol Genet Metab 104 2011 301 307
22. C.H. Yoon, T.J. Youn, S. Ahn, D.J. Choi, G.Y. Cho, and I.H. Chae Low serum total cholesterol level is a surrogate marker, but not a risk factor, for poor outcome in patients hospitalized with acute heart failure: a report from the Korean Heart Failure Registry J Card Fail 18 2012 194 201
23. A.S. Levey, J. Coresh, T. Greene, L.A. Stevens, Y.L. Zhang, and S. Hendriksen Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
24. P.C. Patel, C.R. Ayers, S.A. Murphy, R. Peshock, A. Khera, and J.A. De Lemos Association of Cystatin C with left ventricular structure and function: the Dallas Heart Study Circ Heart Fail 2 2009 98 104
25. U.D. Mathisen, T. Melsom, O.C. Ingebretsen, T. Jenssen, I. Njolstad, and M.D. Solbu Estimated GFR associates with cardiovascular risk factors independently of measured GFR J Am Soc Nephrol 22 2011 927 937
26. A.D. Rule, and J.C. Lieske Cystatin C is more than GFR, and this may be a good thing J Am Soc Nephrol 22 2011 795 797
27. S. Ather, W. Chan, B. Bozkurt, D. Aguilar, K. Ramasubbu, and A.A. Zachariah Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J Am Coll Cardiol 59 2012 998 1005
28. D.S. Sherman, D.N. Fish, and I. Teitelbaum Assessing renal function in cirrhotic patients: problems and pitfalls Am J Kidney Dis 41 2003 269 278